Moffitt Cancer Center’s 2020 Update on MPNs: Is Ruxolitinib Beneficial? Will the Disease Develop With Inflammation? How Do IL-1Beta & TNF-Alpha Work?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Moffitt Cancer Center’s 2020 Update on MPNs: Is Ruxolitinib Beneficial? Will the Disease Develop With Inflammation? How Do IL-1Beta & TNF-Alpha Work?

By Moffitt Cancer Center FEATURING Andrew Kuykendall

477 views

December 15, 2020

As a result of participating in this activity, the learner will be able to:
Define ...
read more ↘ the molecular basis for myeloproliferative neoplasms (MPNs);
Discuss the concept of MPNs as hematologic malignancies that are cultivated by and produce inflammatory states;
Evaluate the rationale behind early intervention and anti-inflammatory therapeutic strategies in the treatment of MPNs
↖ read less

0 Comments